11C-Metomidate
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 11C-Metomidate, covering 2025-12-02 to 2025-12-02. Get the full timeline:
Most recent: Clinical Trial Update: 11C-Metomidate PET/CT for Endocrine Hypertension and Characterisation of Adrenal Tumours [Phase 2, Phase 3]